N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2,3-dihydro-1,4-benzoxathiin-2-methanamine
-
N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2,3-dihydro-1,4-benzoxathiin-2-methanamine
structure -
-
CAS No:
92642-94-9
-
Formula:
C19H23NO4S
-
Chemical Name:
N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2,3-dihydro-1,4-benzoxathiin-2-methanamine
-
Synonyms:
1,4-Benzoxathiin-2-methanamine,N-[2-(2,6-dimethoxyphenoxy)ethyl]-2,3-dihydro-;N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2,3-dihydro-1,4-benzoxathiin-2-methanamine;143542-81-8
-
CAS No:
N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2,3-dihydro-1,4-benzoxathiin-2-methanamine Basic Attributes
361.46
361.46
Drug Information
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
2-(((2-(2,6-dimethoxyphenoxy)ethyl)amino)methyl)-1,4-benzoxathian
Computed Properties
Molecular Weight:361.5
XLogP3:3.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:8
Exact Mass:361.13477939
Monoisotopic Mass:361.13477939
Topological Polar Surface Area:74.2
Heavy Atom Count:25
Complexity:374
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2,3-dihydro-1,4-benzoxathiin-2-methanamine
SDSRequest for Quotation